{"id":"https://openalex.org/W2782019971","doi":null,"title":"Deficiency of topoisomerase II-alpha is associated with increased susceptibility to melphalan","display_name":"Deficiency of topoisomerase II-alpha is associated with increased susceptibility to melphalan","publication_year":1997,"publication_date":"1997-12-11","ids":{"openalex":"https://openalex.org/W2782019971","mag":"2782019971"},"language":"en","primary_location":{"id":"mag:2782019971","doi":null,"is_oa":false,"landing_page_url":"https://eurekamag.com/research/030/812/030812184.php","pdf_url":null,"source":{"id":"https://openalex.org/S4306523954","display_name":"Proceedings of the American Association for Cancer Research Annual Meeting","issn_l":"0569-2261","issn":["0569-2261"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Proceedings of the American Association for Cancer Research Annual Meeting","raw_type":null},"volume":null,"type":"article","indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007588723","display_name":"Haruyo Hirota","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Haruyo Hirota","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032644557","display_name":"Sumantra Chatterjee","orcid":"https://orcid.org/0000-0002-5076-1698","observed_orcids":["https://orcid.org/0000-0002-5076-1698"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sumantra Chatterjee","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-5076-1698","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5037635525","display_name":"Nathan A. Berger","orcid":"https://orcid.org/0000-0001-7086-9885","observed_orcids":["https://orcid.org/0000-0001-7086-9885"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nathan A. Berger","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7086-9885","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.22909741,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"38","issue":null,"first_page":"19","last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12356","display_name":"Bioactive Compounds and Antitumor Agents","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/topoisomerase-ii-alpha","display_name":"TOP2A","score":0.9240000247955322},{"id":"https://openalex.org/keywords/melphalan","display_name":"melphalan","score":0.9950000047683716},{"id":"https://openalex.org/keywords/drug-sensitivity","display_name":"drug sensitivity","score":0.6370000243186951},{"id":"https://openalex.org/keywords/topoisomerase-ii-inhibitors","display_name":"topoisomerase II inhibitors","score":0.7120000123977661},{"id":"https://openalex.org/keywords/topoisomerase-ii","display_name":"topoisomerase II","score":0.6290000081062317}],"concepts":[{"id":"https://openalex.org/C2778684742","wikidata":"https://www.wikidata.org/wiki/Q2298283","display_name":"Melphalan","level":3,"score":0.5304669141769409},{"id":"https://openalex.org/C64943373","wikidata":"https://www.wikidata.org/wiki/Q2651003","display_name":"Alpha (finance)","level":4,"score":0.4976053535938263},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.33742886781692505},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.324310839176178},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.31522274017333984},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2647370994091034},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.15084177255630493},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.10493797063827515},{"id":"https://openalex.org/C49453240","wikidata":"https://www.wikidata.org/wiki/Q1592163","display_name":"Construct validity","level":3,"score":0.0},{"id":"https://openalex.org/C2775944032","wikidata":"https://www.wikidata.org/wiki/Q22907659","display_name":"Patient satisfaction","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2782019971","doi":null,"is_oa":false,"landing_page_url":"https://eurekamag.com/research/030/812/030812184.php","pdf_url":null,"source":{"id":"https://openalex.org/S4306523954","display_name":"Proceedings of the American Association for Cancer Research Annual Meeting","issn_l":"0569-2261","issn":["0569-2261"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Proceedings of the American Association for Cancer Research Annual Meeting","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2116968980","https://openalex.org/W3197247297","https://openalex.org/W2022172998","https://openalex.org/W2473218232","https://openalex.org/W7015355928","https://openalex.org/W2404342288","https://openalex.org/W2495063782","https://openalex.org/W2077379276","https://openalex.org/W2351338966","https://openalex.org/W2519570568"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-07-28T07:46:37.118299","created_date":"2018-01-12T00:00:00"}